Home › Essential Thrombocythemia › Ohio
Pag-aaral pangklinika para sa Essential Thrombocythemia sa Ohio
6 pag-aaral para sa Essential Thrombocythemia ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07441694A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Cleveland Clinic Taussig Cancer Ctr, Cleveland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07623200A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06351631A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06661915A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Site US05, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07849231A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Cleveland Clinic, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.